FindTrial
Sign In

Use of treatment with low power laser in canker sores and skin burns caused by radiation therapy in patients with head and neck cancer

Use of low level laser therapy for treatment of radiation induced mucositis and radiodermatitis in patients with head and neck cancer - ULMU: low-level laser therapy for Oral Mucositis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-67hjmn
Enrollment
Unknown
Registered
2016-10-21
Start date
2015-12-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiodermatitis. Stomatitis.

Interventions

Application of laser therapy of low intensity, LED type (GaA1As and InGaAlP), in red wavelengths (600-700 nm) and infrared (700-850 nm).'The amount of energy per point is 9.0 J distributed on the peri
Device
E02.594.540
C06.405.205.798

Sponsors

Univesrsidade Estadual de Montes Claros
Lead Sponsor
Univesrsidade Estadual de Montes Claros
Collaborator

Eligibility

Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals with a confirmed histopathologic diagnosis Squamous cell carcinoma of head and neck; 2) Individuals should have at least 20 years old; Need of radiotherapy treatmentd; Agreement to participate in the study, signed the consent form.

Exclusion criteria

Exclusion criteria: Individuals who are not able or have limitations that prevent them from responding to questionnaires.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is pain reduction in the patient after treatment. To assess the patient's pain will be used multidimensional scale for assessing pain. To determine whether there was a reduction of pain is compared to the number of sessions required to reduce pain between groups. It is important to point out that the statistical test that is best suited for this assessment can only be set after data collection.;The secondary endpoint is the reduction in the use of painkillers. To evaluate the reduction in analgesic use will be evaluated prescriptions during treatment. To determine whether there was a reduction in the use of analgesics are compared the number of sessions in use of analgesics.—

Secondary

MeasureTime frame
The laser reduces pain and improves the quality of life of the patient with head and neck cancer. Measured by comparing the WHOQOL between the case group (red and infrared laser) and control group (red laser only).—

Countries

Brazil

Contacts

Public ContactAndré Guimarães

Univesrsidade Estadual de Montes Claros

andreluizguimaraes@gmail.com55 38 9 8831 3705

Outcome results

None listed

Source: REBEC (via WHO ICTRP)